Feeds › Planned insider sales
Planned insider sales
Notices (SEC Form 144) that executives and other insiders file before selling shares, and whether a sale was reported afterwards.
About this data
- What it is
- Before an executive, director or large owner sells restricted or control shares, they file a short notice with the SEC, called Form 144, saying how many shares they plan to sell, through which broker and roughly when. This feed lists those notices, and for each one shows whether a sale was reported afterwards on a Form 4 and how many days later.
- Who files it
- The person selling, or their broker, on the day the sale is placed. Electronic notices start in April 2023.
- How current
- We collect new notices throughout the day on SEC business days.
- Terms
- Form 144The notice an insider or other affiliate of a company files with the SEC before selling restricted or control shares, so the shares can be sold under Rule 144. The notice says how many shares, through which broker, and roughly when.10b5-1 planA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan.
- Worth knowing
- A notice is a plan, not a sale: the person may sell fewer shares, later, or not at all. The value is the one the filer typed, at a price they chose, not what the shares sell for. Many sales are routine, made to diversify or pay taxes, or under a 10b5-1 plan set up months earlier. A blank in the last column does not mean no sale: the person may not have to file a Form 4 (an ordinary affiliate does not), the sale may be recent, or the Form 4 may name a different spelling of the person. We match by the filer's number first and by name second. Information, not investment advice.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Form 144 notices per day, last 30 days
All notices Notices that give a 10b5-1 plan
By the day each notice was filed. A notice is a plan to sell, not a sale.
Latest notices of planned insider sales
Showing: ticker NVMI
| Filed | Insider | Company | Shares to sellA notice is a plan, not a sale. The person may sell fewer shares, sell later, or not sell at all, and the number of shares is what they expect to sell on the day they file. | ValueThe aggregate market value the filer typed on the notice: the shares times a price the filer chose. It is not what the shares will sell for. | PlanA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan. | Expected sale | Sale reportedInsiders who are officers, directors or hold more than 10% report their sales on a Form 4, within two business days. We look for the first Form 4 with an open-market sale by the same person in the same company within 90 days of the notice, and show how many days after the notice it was filed. A blank means we found none: the person may not have sold, may not have to file a Form 4, or the Form 4 may be one we do not have. | Notice |
|---|---|---|---|---|---|---|---|---|
| Nov 10, 2026 | Rani (Raanan) Cohen Director | NVMI Nova Ltd. | 3,121 | $1.0M | 10b5-1 | Nov 10, 2026 | Form 4 ↗ 2 days later · 2,456 shares | Form 144 ↗ |
| Sep 22, 2026 | Shay Wolfling Officer | NVMI Nova Ltd. | 3,864 | $1.4M | 10b5-1 | Sep 21, 2026 | Form 4 ↗ same day · 3,864 shares | Form 144 ↗ |
| Jul 2, 2026 | Gabriel Waisman Officer | NVMI Nova Ltd. | 4,466 | $2.2M | 10b5-1 | Jul 2, 2026 | Form 4 ↗ 4 days later · 2,966 shares | Form 144 ↗ |
| Jun 22, 2026 | Garty Yaniv Director | NVMI Nova Ltd. | 366 | $210.6K | 10b5-1 | Jun 22, 2026 | Form 4 ↗ 3 days later · 366 shares | Form 144 ↗ |
| May 26, 2026 | Oppenhaim Eitan Director | NVMI Nova Ltd. | 2,794 | $1.4M | 10b5-1 | May 26, 2026 | Form 4 ↗ 1 day later · 1,504 shares | Form 144 ↗ |
| May 18, 2026 | Sagiv Sarit Director | NVMI Nova Ltd. | 1,246 | $634.4K | 10b5-1 | May 18, 2026 | Form 4 ↗ 2 days later · 426 shares | Form 144 ↗ |
| May 18, 2026 | Simon Zehava Director | NVMI Nova Ltd. | 1,246 | $634.4K | 10b5-1 | May 18, 2026 | Form 4 ↗ 2 days later · 426 shares | Form 144 ↗ |
| May 18, 2026 | Garty Yaniv Director | NVMI Nova Ltd. | 426 | $216.9K | 10b5-1 | May 18, 2026 | Form 4 ↗ 2 days later · 426 shares | Form 144 ↗ |
| Feb 17, 2026 | Gabriel Waisman Officer | NVMI Nova Ltd. | 3,125 | $1.4M | 10b5-1 | Feb 17, 2026 | — | Form 144 ↗ |
| Feb 17, 2026 | Wolfing Shay Officer | NVMI Nova Ltd. | 9,346 | $4.1M | 10b5-1 | Feb 17, 2026 | — | Form 144 ↗ |
| Feb 17, 2026 | Adrian Stuart Wilson Officer | NVMI Nova Ltd. | 3,046 | $1.4M | 10b5-1 | Feb 17, 2026 | — | Form 144 ↗ |
| Dec 16, 2025 | Aboody Efraim Director | NVMI Nova Ltd. | 6,850 | $2.2M | 10b5-1 | Dec 16, 2025 | — | Form 144 ↗ |
| Dec 8, 2025 | Simon Zehava Director | NVMI Nova Ltd. | 160 | $51.9K | 10b5-1 | Dec 8, 2025 | — | Form 144 ↗ |
| Oct 2, 2025 | Simon Zehava Director | NVMI Nova Ltd. | 1,360 | $434.7K | 10b5-1 | Oct 1, 2025 | — | Form 144 ↗ |
| Sep 23, 2025 | Simon Zehava Director | NVMI Nova Ltd. | 852 | $263.8K | 10b5-1 | Sep 22, 2025 | — | Form 144 ↗ |
| Sep 16, 2025 | Sagiv Sarit Director | NVMI Nova Ltd. | 426 | $124.9K | 10b5-1 | Sep 15, 2025 | — | Form 144 ↗ |
| Sep 16, 2025 | Guy Kizner Officer | NVMI Nova Ltd. | 1,500 | $439.6K | 10b5-1 | Sep 15, 2025 | — | Form 144 ↗ |
| Sep 16, 2025 | Simon Zehava Director | NVMI Nova Ltd. | 479 | $140.4K | 10b5-1 | Sep 15, 2025 | — | Form 144 ↗ |
| Sep 11, 2025 | Sagiv Sarit Director | NVMI Nova Ltd. | 1,281 | $356.3K | 10b5-1 | Sep 11, 2025 | — | Form 144 ↗ |
| Sep 8, 2025 | Wolfing Shay Officer | NVMI Nova Ltd. | 6,667 | $1.7M | 10b5-1 | Sep 8, 2025 | — | Form 144 ↗ |
| Sep 4, 2025 | Adrian Stuart Wilson Officer | NVMI Nova Ltd. | 2,220 | $526.5K | — | Sep 3, 2025 | — | Form 144 ↗ |
| Jul 1, 2025 | Simon Zehava Director | NVMI Nova Ltd. | 1,390 | $372.0K | 10b5-1 | Jun 30, 2025 | — | Form 144 ↗ |
| Jun 27, 2025 | Simon Zehava Director | NVMI Nova Ltd. | 720 | $183.9K | 10b5-1 | Jun 26, 2025 | — | Form 144 ↗ |
| Jun 26, 2025 | Guy Kizner Officer | NVMI Nova Ltd. | 2,051 | $509.7K | 10b5-1 | Jun 25, 2025 | — | Form 144 ↗ |
| Jun 25, 2025 | Oppenhaim Eitan Officer | NVMI Nova Ltd. | 16,132 | $3.8M | 10b5-1 | Jun 24, 2025 | — | Form 144 ↗ |
| Jun 12, 2025 | Guy Kizner Officer | NVMI Nova Ltd. | 1,000 | $226.2K | 10b5-1 | Jun 11, 2025 | — | Form 144 ↗ |
| Jun 2, 2025 | Gabriel Waisman Officer | NVMI Nova Ltd. | 12,000 | $2.6M | 10b5-1 | Jun 2, 2025 | — | Form 144 ↗ |
| May 28, 2025 | Adrian Stuart Wilson Officer | NVMI Nova Ltd. | 3,030 | $554.5K | 10b5-1 | May 27, 2025 | — | Form 144 ↗ |
| May 20, 2025 | Garty Yaniv Director | NVMI Nova Ltd. | 961 | $184.3K | 10b5-1 | May 19, 2025 | — | Form 144 ↗ |
| Mar 5, 2025 | Cohen Raanan Director | NVMI Nova Ltd. | 8,205 | $1.8M | 10b5-1 | Mar 5, 2025 | — | Form 144 ↗ |
| Mar 4, 2025 | Wolfing Shay Officer | NVMI Nova Ltd. | 11,166 | $2.5M | 10b5-1 | Mar 4, 2025 | — | Form 144 ↗ |
| Mar 4, 2025 | Simon Zehava Director | NVMI Nova Ltd. | 1,500 | $358.8K | 10b5-1 | Mar 3, 2025 | — | Form 144 ↗ |
| Feb 20, 2025 | David Dror Officer | NVMI Nova Ltd. | 649 | $177.2K | — | Feb 19, 2025 | — | Form 144 ↗ |
| Jan 17, 2025 | Sagiv Sarit Director | NVMI Nova Ltd. | 400 | $93.1K | 10b5-1 | Jan 16, 2025 | — | Form 144 ↗ |
| Dec 11, 2024 | Sagiv Sarit Director | NVMI Nova Ltd. | 804 | $159.6K | 10b5-1 | Dec 10, 2024 | — | Form 144 ↗ |
| Dec 10, 2024 | Adrian Stuart Wilson Officer | NVMI Nova Ltd. | 3,400 | $663.6K | 10b5-1 | Dec 9, 2024 | — | Form 144 ↗ |
| Dec 5, 2024 | David Dror Officer | NVMI Nova Ltd. | 1,685 | $318.3K | — | Dec 4, 2024 | — | Form 144 ↗ |
| Nov 21, 2024 | Adrian Stuart Wilson Officer | NVMI Nova Ltd. | 3,166 | $551.5K | 10b5-1 | Nov 21, 2024 | — | Form 144 ↗ |
| Oct 3, 2024 | Adrian Stuart Wilson Officer | NVMI Nova Ltd. | 976 | $193.1K | — | Oct 2, 2024 | — | Form 144 ↗ |
| Sep 4, 2024 | David Dror Officer | NVMI Nova Ltd. | 4,275 | $955.7K | — | Sep 3, 2024 | — | Form 144 ↗ |
| Sep 4, 2024 | Adrian Stuart Wilson Officer | NVMI Nova Ltd. | 2,356 | $526.7K | — | Sep 3, 2024 | — | Form 144 ↗ |
| Sep 4, 2024 | Sagiv Sarit Director | NVMI Nova Ltd. | 906 | $182.7K | 10b5-1 | Sep 4, 2024 | — | Form 144 ↗ |
| Sep 3, 2024 | Gabriel Waisman Officer | NVMI Nova Ltd. | 6,229 | $1.4M | 10b5-1 | Sep 3, 2024 | — | Form 144 ↗ |
| Aug 14, 2024 | Wolfing Shay Officer | NVMI Nova Ltd. | 6,413 | $1.5M | 10b5-1 | Aug 14, 2024 | — | Form 144 ↗ |
| Jul 1, 2024 | Oppenhaim Eitan Director | NVMI Nova Ltd. | 41,404 | $9.7M | 10b5-1 | Jul 1, 2024 | — | Form 144 ↗ |
| Jun 25, 2024 | Simon Zehava Director | NVMI Nova Ltd. | 410 | $91.9K | 10b5-1 | Jun 25, 2024 | — | Form 144 ↗ |
| May 22, 2024 | Cohen Raanan Officer | NVMI Nova Ltd. | 7,796 | $1.6M | 10b5-1 | May 22, 2024 | — | Form 144 ↗ |
| May 22, 2024 | Aboody Efraim Officer | NVMI Nova Ltd. | 4,097 | $836.2K | 10b5-1 | May 22, 2024 | — | Form 144 ↗ |
| Feb 20, 2024 | Wolfing Shay Officer | NVMI Nova Ltd. | 5,690 | $961.3K | 10b5-1 | Feb 20, 2024 | — | Form 144 ↗ |
| Feb 20, 2024 | David Dror Officer | NVMI Nova Ltd. | 649 | $109.6K | 10b5-1 | Feb 20, 2024 | — | Form 144 ↗ |
The newest 50 items, most recent first. Every row links to the notice on the SEC's site, and to the Form 4 when we found one. Updated Nov 15, 2026, 8:24 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances